158 related articles for article (PubMed ID: 12473651)
1. Characterization of a novel negative regulator (DOC-2/DAB2) of c-Src in normal prostatic epithelium and cancer.
Zhou J; Scholes J; Hsieh JT
J Biol Chem; 2003 Feb; 278(9):6936-41. PubMed ID: 12473651
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade. DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2.
Zhou J; Hsieh JT
J Biol Chem; 2001 Jul; 276(30):27793-8. PubMed ID: 11371563
[TBL] [Abstract][Full Text] [Related]
3. The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.
Zhoul J; Hernandez G; Tu SW; Huang CL; Tseng CP; Hsieh JT
Cancer Res; 2005 Nov; 65(21):9906-13. PubMed ID: 16267015
[TBL] [Abstract][Full Text] [Related]
4. The role of DOC-2/DAB2 protein phosphorylation in the inhibition of AP-1 activity. An underlying mechanism of its tumor-suppressive function in prostate cancer.
Tseng CP; Ely BD; Pong RC; Wang Z; Zhou J; Hsieh JT
J Biol Chem; 1999 Nov; 274(45):31981-6. PubMed ID: 10542228
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.
Wang Z; Tseng CP; Pong RC; Chen H; McConnell JD; Navone N; Hsieh JT
J Biol Chem; 2002 Apr; 277(15):12622-31. PubMed ID: 11812785
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle.
Zhou J; Fan J; Hsieh JT
Cancer Res; 2006 Sep; 66(18):8954-8. PubMed ID: 16982733
[TBL] [Abstract][Full Text] [Related]
7. Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation.
He J; Smith ER; Xu XX
J Biol Chem; 2001 Jul; 276(29):26814-8. PubMed ID: 11359772
[TBL] [Abstract][Full Text] [Related]
8. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
10. Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor.
Ren Y; Meng S; Mei L; Zhao ZJ; Jove R; Wu J
J Biol Chem; 2004 Feb; 279(9):8497-505. PubMed ID: 14665621
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Wnt signaling pathway by disabled-2 (Dab2).
Hocevar BA; Mou F; Rennolds JL; Morris SM; Cooper JA; Howe PH
EMBO J; 2003 Jun; 22(12):3084-94. PubMed ID: 12805222
[TBL] [Abstract][Full Text] [Related]
12. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
13. Src-family tyrosine kinases, phosphoinositide 3-kinase and Gab1 regulate extracellular signal-regulated kinase 1 activation induced by the type A endothelin-1 G-protein-coupled receptor.
Bisotto S; Fixman ED
Biochem J; 2001 Nov; 360(Pt 1):77-85. PubMed ID: 11695994
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
15. Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling.
Bayle J; Letard S; Frank R; Dubreuil P; De Sepulveda P
J Biol Chem; 2004 Mar; 279(13):12249-59. PubMed ID: 14707129
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine phosphorylation of beta-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins.
Sotgia F; Lee H; Bedford MT; Petrucci T; Sudol M; Lisanti MP
Biochemistry; 2001 Dec; 40(48):14585-92. PubMed ID: 11724572
[TBL] [Abstract][Full Text] [Related]
17. Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.
Schreiner SJ; Schiavone AP; Smithgall TE
J Biol Chem; 2002 Nov; 277(47):45680-7. PubMed ID: 12244095
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase.
Lee LF; Guan J; Qiu Y; Kung HJ
Mol Cell Biol; 2001 Dec; 21(24):8385-97. PubMed ID: 11713275
[TBL] [Abstract][Full Text] [Related]
19. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
20. The critical role of c-Src and the Shc/Grb2/ERK2 signaling pathway in angiotensin II-dependent VSMC proliferation.
Sayeski PP; Ali MS
Exp Cell Res; 2003 Jul; 287(2):339-49. PubMed ID: 12837289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
